Product Information
FOSFOMYCIN 3 GM SACHET is a generic product labeled by Xiromed LLC, priced at $29.8695 per EA under NDC 70700026894. Its NADAC has been published 284 times since Jan 20, 2021.
Strength
3 g/1
Manufacturer
Xiromed LLCNDC
70700026894
Classification
Generic
Dosage Form
POWDER
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FOSFOMYCIN TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA212548On Market Since
10/6/2020
Price Statistics
The NADAC for FOSFOMYCIN 3 GM SACHET has been published 284 times since Jan 20, 2021, and over the history we have for it it has declined 58.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $29.8695 per EA |
|---|---|
| All-time high | $71.3767 (Feb 10, 2021) |
| All-time low | $29.8695 (Jun 17, 2026) |
| 52-week high | $41.6679 |
| 52-week low | $29.8695 |
| Median price | $49.5408 |
| Average price | $51.2344 |
| Largest weekly change | -35.0% (Apr 17, 2024) |
| Weeks tracked | 284 |
| Tracking since | Jan 20, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FOSFOMYCIN 3 GM SACHET?
The current National Average Drug Acquisition Cost (NADAC) for FOSFOMYCIN 3 GM SACHET, manufactured by Xiromed LLC, is $29.8695 per EA (NDC 70700026894), effective Jun 24, 2026.
How has the price of FOSFOMYCIN 3 GM SACHET changed over time?
Over the history we have for it, the NADAC for FOSFOMYCIN 3 GM SACHET has declined 58.2%. It has been tracked across 284 weekly CMS publications since Jan 20, 2021.
What are the highest and lowest recorded NADAC prices for FOSFOMYCIN 3 GM SACHET?
Since Jan 20, 2021, the NADAC for FOSFOMYCIN 3 GM SACHET has ranged from a low of $29.8695 (Jun 17, 2026) to a high of $71.3767 (Feb 10, 2021), with a median of $49.5408 per EA.
Are there cheaper alternatives to FOSFOMYCIN 3 GM SACHET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as FOSFOMYCIN 3 GM SACHET, but none are currently priced below it.
Who manufactures FOSFOMYCIN 3 GM SACHET?
FOSFOMYCIN 3 GM SACHET (NDC 70700026894) is labeled by Xiromed LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification